Protein anabolic action of insulin, growth hormone and insulin-like growth factor I

European Journal of Endocrinology

Volumn 135, Issue 6, 1996, Pages 631-642

  Russell Jones, David L ^a   Umpleby, Margot ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW;

EID: 0030483479     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350631     Document Type: Review

References (144)

1. Waterlow JC. Protein turnover in the whole animal. Invest Cell Pathol 1980;3:107-19
2. Laurent GJ, Sparrow MP, Millward DJ. Turnover of muscle protein in the fowl. Changes in rates of protein synthesis and breakdown during hypertrophy of the anterior and posterior latissimus dorsi muscles. Biochem J 1978;176:407-17
3. Millward DJ, Waterlow JC. Effect of nutrition on protein turnover in skeletal muscle. Fed Prod 1978;37:2283-90
4. Jahoor F, Wolfe RR. Regulation of protein catabolism. Kidney Int 1987;52:S81-93
5. Ballard FJ, Thomas FM. 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use. Clin Sci 1983;65:209-15
6. Sprinson BD, Rittenberg D. The rate of interaction of the amino acids of the diet with the tissue proteins. J Biol Chem 1949;180: 715-26
7. 15N end-product methods for the study of whole body protein turnover. Proc Nutr Soc 1981;40:317-20
8. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sonksen PH. The effect of metabolic control on leucine metabolism in type 1 insulin-dependent diabetic patients. Diabetologia 1986; 29:131-41
9. 13C]-leucine. Am J Physiol 1980;238: E473-9
10. 15N]lysine. Clin Sci Mol Med 1975;49:581-90
11. 13C]leucine. Clin Sci 1989;77:329-36
12. 5]pheylalanine model. Am J Physiol 1989; 256:E6 31-9
13. Millward DJ, Waterlow JC. Effect of nutrition on protein turnover in skeletal muscle. Fed Proc 1978;37:2283-90
14. Hammerquist F, Wernerman J. Van der Decken A, Vinnars E. The effect of branched chain amino-acids upon postoperative muscle protein synthesis and nitrogen balance. Clin Nutr 1988;7:171-5
15. Flaim KE, Hutson SM, Lloyd CE, Taylor JM, Shiman R, Jefferson LS. Direct effect of insulin on albumin gene expression in primary cultures of rat hepatocytes. Am J Physiol 1985;249: E447-53
16. Dillman WH. Diabetes mellitus induced changes in the concentrations of specific mRNAs and proteins. Diabetes/ Metab Rev 1988;4:789-97
17. Granner DK, Andreone T, Sasaki T, Beale E. Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 1983;305:549-51
18. Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID. Mechnaisms of insulin-induced insulin-receptor down regulation: decrease of receptor biosynthesis and mRNA levels. Diabetes 1990;38:182-7
19. Ashford AJ, Pain VM. Effect of diabetes on the rate of synthesis and degradation of ribosome in rat muscle and liver in vivo. J Biol Chem 1986;261:4059-65
20. Ashford AJ, Pain VM. Insulin stimulation of growth in diabetic rats: synthesis and degradation of ribosomes and total muscle protein in skeletal muscle and heart. J Biol Chem 1986;261: 4066-70
21. Harmon CS, Proud CG, Pain VM. Effects of starvation, diabetes and acute insulin treatment on the regulation of polypeptide-chain initiation in rat skeletal muscle. Biochem J 1984;223: 687-96
22. Flaim KE, Copenhaver ME, Jefferson LS. Effects of diabetes on protein synthesis in fast and slow twitch skeletal muscle. Am J Physiol 1980;239:E88-85
23. Peavy DE, Taylor JM, Jefferson LS. Correlation of albumin production rates and albumin RNA in livers of normal, diabetic, and insulin-treated diabetic rats. Proc Natl Acad Sci USA 1978; 75:5879-83
24. Manchester KL. Effect of insulin on protein synthesis. Diabetes 1972:21 Suppl 2:447-52
25. Jefferson LS, Rannels DE, Munger BL, Morgan HE. Insulin in the regulation of protein turnover in heart and skeletal muscle. Fed Proc 1974;33:1098-104
26. Williams IH, Chua BHL, Sahms RH, Siehl D, Morgan HE. Effects of diabetes on protein turnover in cardiac muscle. Am J Physiol 1980;239:E178-85
27. Jefferson LS, Li BJ, Rannels SR. Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus. J Biol Chem 1977;252:1476-83
28. Mortimore GE, Poso AR, Lardeux BR. Mechanism and regulation of protein degradation in liver. Diabetes Metab Rev 1989;5: 48-70
29. Smith DM, Sugden PH. Contrasting response of protein degradation to starvation and insulin as measured by release of N-methyl histidine or phenylalanine from the perfused rat heart. Biochem J 1986;237:391-5
30. Smith OLK, Wong CY, Gefland RA. Skeletal muscle proteolysis in rats with acute streptozotocin-induced diabetes. Diabetes 1989; 38:1117-22
31. Mortimore GA, Ward WF, Schworer CM. Lysosomal processing of intracellular proteins in rat liver and its general regulation by amino acids and insulin. In: Segal HL, Dole DJ, editors. Protein turnover and lysosome function. New York: Academic Press, 1978:67-87
32. Kettlehut IV, Wing SS, Goldberg AL. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes/Metab. Rev 1988;4:751-72
33. Libby P, Golberg AL. Comparisons of the control and pathways for degradation of the acetyl choline receptor and average protein in cultured muscle cells. J Cell Physiol 1981;107: 185-94
34. Lowell BB, Ruderman NB, Goodman MN. Evidence that lysosomes are not involved in the degradation of myotibrillar proteins in rat skeletal muscle. Biochem J 1986;234:237-40
35. Rechsteiner M. Ubiquitin-mediated protein degradation. Annu Rev Cell Biol 1987;3:1-30
36. Medina R, Wing SS, Golberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 1995; 307:631-7
37. Albertse EC, Pain VM, Garlick PJ. Whole body protein synthesis and oxidation rates in streptozotocin diabetic rats. Proc Nutr Soc 1979;38:125A
38. Pain WM and Garlick PJ. Effect of streptozotocin diabetes and insulin treatment on the rate of protein synthesis in tissues of the rat in vivo. J Biol Chem 1974;249:4510-4
39. Pain VM, Albertse EC, Garlick PJ. Protein metabolism in skeletal muscle, diaphragm and heart of diabetic rats. Am J Physiol 1983;245:E604-10
40. Nair KS, Halliday D, Garrow JS, Mahler RE. Effect of poor diabetic control and obesity on whole body protein turnover. Clin Sci 1983;64:36-40
41. Tessari P, Nosadini R, Trevisan R, de Kreutzenberg SV, Inchiostro S, Duner E, et al. Defective suppression by insulin of leucine-carbon appearance and oxidation in Type 1 insulin dependent diabetes mellitus: evidence for insulin resistance. J Clin Invest 1986;77:1797-804
42. Tessari P, Trevisan R, Inchiostro S, de Kreutzenberg SV, Biolo G, Nosadini R. et al. Dose response curves of the effects of insulin on leucine kinetics in man. Am J Physiol 1986;251:E334-43
43. Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews, DE, Bier DE, et al. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism. J Clin Invest 1985;76:2306-11
44. Flakoll, PJ, Kulaylat M, Frexes-Steed M, Hourani H, Brown L, Hill JO, et al. Amino acids augment insulin's suppression of whole body proteolysis. Am J Physiol 1989;257:E838-47
45. Russell-Jones DL, Umpleby AM, Hennessy TR, Bowes SB, Shojaee-Moradie F, Hopkins KD, et al. Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 1994;267:E591-8
46. 13C]leucine. Diabetologia 1990;33: 43-51
47. Tessari P, Inchiostro S, Btolo G, Trevisan R, Fantin G, Marescotti MC. et al. Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in regulation of net amino acid deposition. J Clin Invest 1987;79:1062-9
48. Catellino P, Luzi L, Simonson DC, Haymond MW, DeFronzo RA. Effect of insulin and plasma amino acid concentration on leucine metabolism in man: role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 1987;80:1784-93
49. Baillie AGS, Garlick PJ, Responses of protein synthesis in different skeletal muscles to fasting and insulin in the rat. Am J Physiol 1991;260:E891-6
50. Baillie AGS, Garlick PJ. Attenuated response of muscle protein synthesis to fasting and insulin in adult female rats. Am J Physiol 1992;262:E1-5
51. Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 1987;80:1-6
52. Louard RJ, Fryburg DA, Gelfand RA, Barrett EJ. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J Clin Invest 1992;90:2348-54
53. Tessari P, Biolo G, Inchiostro S, Sacca L, Nosadini R, Boscarato MT, et al. Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes. Am J Physiol 1990; 269:E96-103
54. Heslin MJE, Newman E, Wolf RF, Pisters PWT. Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans. Am J Physiol 1992;262:E911-8
55. Bennet WM, Connacher AA, Jung RT, Stehle P, Rennie MJ. Effects of insulin and amino acids on leg protein turnover in IDDM patients. Diabetes 1991;40:499-508
56. Pacy PJK, Nair KS, Ford CG, Halliday D. Failure of insulin infusion to stimulate fractional muscle protein synthesis in type I diabetic patients. Diabetes 1989;38:618-24
57. 13C leucine. Clin Sci 1989;76:447-54
58. Lundholm K, Schersten T. Protein synthesis in human skeletal muscle tissue: influence of insulin and amino acids. Eur J Clin Invest 1977;7:531-6
59. Biolo G, Tessari P, Inchiostro S, Bruttomeso D, Fongher C, Sabadin, et al. Leucine and phenylalanine kinetics during mixing meal ingestion. A multiple tracer approach. Am J Physiol 1992;262:E455-63
60. Tessari P, Pehling G, Nissen SL, Gerich JE, Service FJ, Rizza RA. et al. Regulation of whole-body leucine metabolism with insulin during mixed meal absorption in normal and diabetic humans. Diabetes 1988;37:512-9
61. Biolo G, Inchiostro S, Sabadin L, Fratton MG, Vettore M, Tiengo A, et al. Insulin-deficiency does not impair selective splanchnic uptake of dietary leucine and phenylalanine. Diabetologia 1991; 34:114A
62. De Feo PP, Volpi E, Lucidi P, Cruciani G, Reboldi GP, Siepi D. et al. Physiological increments in plasma insulin concentrations have selective and different effects on hepatic protein synthesis in normal humans. Diabetes 1993;42:995-102
63. De Feo P, Gan Gaisano M, Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 1991;88:833-40
64. Pacy PJ, Read MA, Halliday D, Influence of insulin on albumin and non-albumin protein fractional synthetic rates in post-absorptive type 1 diabetic patients. Eur J Clin Nutr 1990;44: 343-34
65. Cummings MH, Watts GF, Umpleby AM, Hennessey TR, Naoumova R, Thompson GR. et al. Increased hepatic secretion of very low density lipoprotein B100 in type 2 diabetes mellitus: a stable isotope study. Diabetologia 1995; 38:959-67
66. Cummings MH, Watts GF, Umpleby AM, Hennessey TR, Kelly JM, Jackson NC, et al. Acute hyperinsulinaemia decreases the hepatic secretion of very low density lipoprotein B100 in NIDDMs. Diabetes 1995;44:1059-65
67. Watts GF, Cummings MH, Kelly JM, Umpleby AM, O'Brien S, Sonksen PH (1996) Acute hyperinsulinaemia decreases the hepatic secretion of very low density lipoprotein B100 in normal subjects. Endocrinol Metab 1996. In press
68. Crowe SJ, Cushing H, Homans J. Experimental hypophysectomy. Bull Johns Hopkins Hosp 1910;21:127
69. Aschner B. Uber die function der hypophyse. Pflugers Arch 1912;146:1
70. Kostyo JL, Knobil E. The effect of growth hormone on the in vitro incorporation of leucine-2-14C into the protein of rat diaphragm. J Endocrinol 1959;65:395-401
71. Kostyo JL. Rapid effects of growth hormone on amino acid transport and protein synthesis. Ann NY Acad Sci 1968; 148:389-407
72. Kostyo JL, Nutting DF. Growth hormone and protein metabolism. In: Creep RO, Astwood E, editors. Handbook of physiology. Washington. D.C.: American Physiological Society. 1974:187-210
73. Kosyto JL. Separation of the effects of growth hormone on muscle amino acid transport and protein synthesis. Endocrinology 1968;75:113-9
74. Maler RJ, Szego C. Early insulin synergistic activity of GH. Diabetes 1969:550-5
75. Albertsson-Wikland K. Edén S. Isaksson O. Analysis of early responses to growth hormone on amino acid transport and protein synthesis in diaphragms of young normal rats. J Endocrinol 1980;106:291-7
76. Cheng JS, Kalant N. Effects of insulin and GH on the flux rates of plasma glucose and plasma FFA in man. J Clin Endocrinol 1970; 31:647-53
77. Goodman HM. Early and late effects of GH on the metabolism of glucose in adipose tissue. Endocrinology 1965;76:1134-40
78. Swislocki NI, Szego C. Acute reduction of plasma NEFA by GH in hypophysectomized and Houssay rats. Endocrinology 1965;76: 665-72
79. Goodman HM. Early and late effects of GH on the metabolism of glucose in adipose tissue. Endocrinology 1965;76:1134-40
80. Tanner JM, Hughes PCR. Whitehouse RH. Comparative rapidity of response of height. limb muscle and limb fat to treatment with human GH in patients with and without GH deficiency. Acta Endocrinol (Copenh) 1977;184:681-96
81. Cheek DB, Hill DE. Muscle and liver cell growth: role of hormone and nutritional factors. Fed Proc 1970;29:1503-9
82. Teal HM, Cushing H. Studies in the physiological properties of the growth promoting extracts of the anterior hypophysis. Endocrinology 1930;14:157-63
83. Kostyo JL, Rillema JA. In vitro effects of GH on the number and activity of ribosomes engaged in protein synthesis in the isolated rat diaphragm. Endocrinology 1971;88:1054-60
84. Milman A, DeMoor P, Lukens FDW. Relation of purified pituitary GH and insulin in regulation of nitrogen balance. Am J Physiol 1951;166:354-66
85. Russell JA. Effects of GH on protein and carbohydrate metabolism. Am J Clin Nutr 1957;5:404-16
86. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-803
87. Cuneo RC, Salomon F, Wiles CM, Sonksen PH. Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 1990:33 Suppl 4:55-60
88. Bengtsson B-A, Eden S, Lonn L, Kvist H. Stokland A, Linstedt G. et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76:309-17
89. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993;77:1671-6
90. Jorgensen JOL, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: near-normalization of body composition and physical performance. Eur J Endocrinol 1994; 130:224-8
91. Horber FF & Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisolone in humans. J Clin Invest 1990;86:265-72
92. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-504
93. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N, Pois HAP, Brikenhager JC, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis. as well as on body composition. Clin Endocrinol 1992;37:79-87
94. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM, et al. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol 1993;38:427-31
95. Jorgensen JOL, Pederson SA, Thuesen L, Jórgensen J. Ingemann-Hansen T. Skakkebaek NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;i: 1221-5
96. Ponting GA, Ward HC, Halliday D, Teale JD, Sim AJW. Protein and energy metabolism with biosynthetic growth hormone in patients on full intravenous nutritional support. JPEN 1990; 14:437-41
97. Lehner JH, Jauch KW, Berger G, Tacke J, Savic B. A multicentre study of the dose response effect of human recombinant GH on cumulative nitrogen balance in patients after major abdominal surgery. Ann Surg 1992;208:6-16
98. Wilmore DW, Moylan JA, Bristow BF, Mason AD, Pruitt BA. Anabolic effects of growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 1974;138: 875-84
99. Ziegler TR, Young LS, Ferrari-Baliviera E, Demlind RH, Wilmore DW. Use of hGH combined with nutritional support in a critical care unit. JPEN 1990;14:574-81
100. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole body and isolated limb protein kinetics in burned patients. Arch Surg 1991;126:38-43
101. Douglas RG, Humberstone DA, Haystead A, Shaw JHF. Metabolic effects of human growth hormone: isotopic studies in the postabsorptive state and during parenteral nutrition. Br J Surg 1990;77:785-90
102. Voerman HJ, Van Schijindel RMS, Groeneveld ABJ, de Boer H, Natua JP, van der Veen EA, et al. Effects of recombinant growth hormone in patients with severe sepsis. Ann Surg 1992;216:648-55
103. Mulligan K, Grunfeld C, Hellerstein MK, Nesse RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1995;77: 956-62
104. Wolf RF, Heslin MJ, Newman E, Pearlstone DB, Gonenne A, Brennan MF. Growth hormone and insulin combine to improve whole body and skeletal muscle protein kinetics. Surgery 1992;112:284-91
105. VVolf RF, Pearlstone DB, Newman E, Heslin MJ, Gonenne A, Burt ME, et al. Growth hormone and insulin reverse net whole body and skeletal muscle protein metabolism in cancer patients. Ann Surg 1992;216:288-90
106. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825-36
107. Taylor AL, Lipman RL, Salam A, Mintz DH. Hepatic clearance of human GH. J Clin Endocrinol 1972;34:395-9
108. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591-614
109. Isaksson O, Ohlsson C, Isgaard J, Lindahl A. Regulation of cartilage growth by growth hormone and insulin-like growth factor I. Pediatr Nephrol 1991;5:451-3
110. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 1991;260:E846-51
111. Harper JMM, Soar JB, Buttery PJ. Changes in protein metabolism of ovine primary muscle cultures on treatment with growth hormone, insulin, insulin-like growth factor I or epidermal growth factor. J Endocrinol 1987;112:87-96
112. Fuller SJ, Mynett JR, Sugden PH. Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem J 1992;282:85-90
113. Florini JR, Nicholson ML, Dulak NC. Effects of peptide anabolic hormones on growth of myoblasts in culture. J Endocrinol 1977;101:32-41
114. Stiles CF, Capone GI, Sher CD, Antoniades HN, Van Wyk JJ, Pledger WJ. Dual control of cell growth by somatomedin and PDGF. Proc Natl Acad Sci USA 1979;76:1279-83
115. Florini JR, Ewton DZ, Falen SL, Van Wyk JJ. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol 1986;250: C771-8
116. Schmid C, Steiner T, Froesch ER. IGF-I supports differentiation of cultured osteoblast-like cells. FEBS Lett 1984;173:48-52
117. McMorris FA, Smith TM, Desalvo S, Furlanetto. IGF-I: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 1986;83:822-6
118. Flier JS, Usher P, Moses AC. Monoclonal antibody to the type I insulin-like (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 1986;83:664-8
119. Banskota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor-I and platelet derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989;3:1183-90
120. Zapf JC, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half lives of intravenous administered IGF-I and II in normal and hypophysectomized rats. J Clin Invest 1986;77: 1768-75
121. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest 1989;83: 1717-23
122. Giacca A, Gupta R, Efendic S, Hall K, Skottner A, Lickley L, et al. Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatectomized dogs. Diabetes 1990; 59:340-7
123. Shojaee-Moradie F, Umpleby AM, Thumason M, Jackson NC, Boroujerdi MA, Sonksen PH, et al. A comparison of the effects of insulin-like growth factor I, insulin and combined infusions of insulin and insulin-like growth factor I on glucose metabolism in dogs. Eur J Clin Invest 1995;25:920-8
124. Douglas RC, Gluckman PD, Ball K, Breier B, Shaw JHF. The effects of infusion of IGF-I. IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 1991;88: 614-22
125. Guler H Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987;317:137-40
126. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor I on glucose, lipid and amino acid metabolism. Am J Physiol 1992;262:E130-3
127. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor I on glucose, lipid and leucine metabolism in man. J Clin Endocrinol Metab 1992;75:1186-91
128. Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP, et al. Effects of recombinant human IGF-I on glucose and leucine kinetics in man. Am J Physiol 1993;265: E831-8
129. Laager R, Ninnis R, Keller U. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. J Clin Invest 1993;92: 1903-9
130. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, Dercole AJ. Expression of IGF-I stimulates normal somatic growth in GH deficient transgenic mice. Endocrinology 1990; 127:1033-40
131. Isgaard J, Nilsson A, Lindahl A, Jansson JO, Isaksson O. Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 1986;250:E367-72
132. Schoenle EJ, Zapf JJ, Hauri C, Steiner. Froesch ER. Comparison of in vivo effects of IGF-I and 1GF-II in hypophysectomized rats. Acta Endocrinol (Copenh) 1985;108:167-74
133. Van Buul-Offers S, Ueda I, Van Den Brande. Biosynthetic somatomedin C/IGF-I increases the length and weight of snell dwarf mice. Pediatr Res 1986;20:825-7
134. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, et al. Growth restoration of insulin deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986;323:169-71
135. Walker JL, Ginalska-Malinowska M, Romer TE, Pucilowska J, Underwood LE. Effects of infusion of IGF-I in a child with growth hormone insensitivity syndrome (Laron Dwarfism) N Engl J Med 1991;324:1483-8
136. Skottner A, Clark RG, Fryklund L, Robinson IC. Growth responses in a mutant dwarf rat to human GH and IGF-I. Endocrinology 1989;124:2519-26
137. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889-93
138. Umpleby AM, Shojaee-Moradie F, Thomason M, Kelly JM, Skottner A, Sonksen PH, et al. Effects of insulin-like growth factor I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs. Eur J Clin Invest 1994;24: 337-44
139. Mauras N, Horber FF, Haymond MW. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretin in humans. J Clin Endocrinol Metab 1992;75:1192-7
140. Fryburg DA, Barrett EJ. Insulin, growth hormone, and IGF-I regulation of protein metabolism. Diabet Rev 1995;3:1
141. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992;75: 234-8
142. Lieberman SA, Butterfield GE, Harrison, D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachetic patients with aquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994;78:404-10
143. Kupfer SR, underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor 1 by use of both agents simultaneously. J Clin Invest 1993;91:391-6
144. Ross RJM, Wilmore DW. Endocrinology in catabolic illness. Endocrinol Metab 1996: Supp 1. In press